Malin Corporation | MLC - Beban Penjualan Dan Administrasi

Harga Saham
7.95
Perubahan Harian
0 0%
Bulanan
3.25%
Tahunan
-6.47%
Q2 Perkiraan
7.71




Beban Penjualan Dan Administrasi Perubahan Tanggal
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
ALKERMES USD 187.2M 15.43M 2025-12
Avita Medical AUD 19.03M 1.95M 2025-12
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Eurofins Scientific SE EUR 0 0 2023-06
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 308M 40M 2025-12
Organon & Co USD 399M 54M 2025-09
Ovoca Bio EUR 632K 2.33M 2025-06
Revvity USD 251.73M 9.82M 2025-12
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Viatris USD 1.03B 144.1M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12